The Goldman Sachs Group Lowers Ryan Specialty (NYSE:RYAN) Price Target to $49.00

Ryan Specialty (NYSE:RYAN) had its price target lowered by stock analysts at The Goldman Sachs Group from $57.00 to $49.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. The Goldman Sachs Group’s price objective suggests a potential upside of 40.50% from the stock’s current price.

Other equities analysts have also recently issued reports about the company. Barclays dropped their price objective on Ryan Specialty from $52.00 to $45.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 11th. UBS Group dropped their price objective on Ryan Specialty from $71.00 to $65.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. Mizuho dropped their price objective on Ryan Specialty from $53.00 to $44.00 and set a “neutral” rating on the stock in a research note on Friday, February 27th. Morgan Stanley dropped their price objective on Ryan Specialty from $55.00 to $50.00 and set an “overweight” rating on the stock in a research note on Monday. Finally, Weiss Ratings cut Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Ryan Specialty currently has an average rating of “Hold” and a consensus price target of $50.44.

Ryan Specialty Price Performance

Shares of RYAN opened at $34.88 on Wednesday. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 2.62. The business’s fifty day moving average is $38.48 and its 200 day moving average is $48.54. Ryan Specialty has a 12-month low of $31.50 and a 12-month high of $75.26. The stock has a market cap of $9.21 billion, a P/E ratio of 83.04, a P/E/G ratio of 0.92 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings data on Thursday, February 12th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.05). Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The company had revenue of $751.21 million for the quarter, compared to the consensus estimate of $777.43 million. During the same quarter last year, the business posted $0.45 earnings per share. Ryan Specialty’s revenue was up 13.2% on a year-over-year basis. Sell-side analysts anticipate that Ryan Specialty will post 2.29 earnings per share for the current fiscal year.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. bought 25,500 shares of the stock in a transaction dated Monday, February 23rd. The shares were bought at an average cost of $39.96 per share, for a total transaction of $1,018,980.00. Following the purchase, the director directly owned 428,295 shares of the company’s stock, valued at approximately $17,114,668.20. This trade represents a 6.33% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 52.03% of the stock is owned by insiders.

Institutional Investors Weigh In On Ryan Specialty

A number of hedge funds have recently made changes to their positions in the business. Fund Advisors of America Inc FL bought a new stake in shares of Ryan Specialty during the 4th quarter worth $277,000. Corient Private Wealth LLC raised its stake in shares of Ryan Specialty by 5.0% during the 4th quarter. Corient Private Wealth LLC now owns 17,807 shares of the company’s stock worth $919,000 after purchasing an additional 840 shares during the period. EJMK Ventures LLC bought a new stake in shares of Ryan Specialty during the 4th quarter worth $1,137,000. Caitong International Asset Management Co. Ltd raised its stake in shares of Ryan Specialty by 491.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,532 shares of the company’s stock worth $79,000 after purchasing an additional 1,273 shares during the period. Finally, Pacer Advisors Inc. increased its holdings in Ryan Specialty by 21.3% in the 4th quarter. Pacer Advisors Inc. now owns 17,988 shares of the company’s stock worth $929,000 after acquiring an additional 3,155 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors.

Ryan Specialty News Summary

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: UBS cut its target from $65 to $59 but kept a “buy” rating, leaving a large implied upside and signaling continued conviction in the company’s medium‑term outlook. UBS lowers PT TickerReport
• Positive Sentiment: Goldman Sachs lowered its PT from $57 to $49 but maintained a “buy” rating, preserving a sizable upside and supporting buyer interest at current levels. Goldman lowers PT
• Positive Sentiment: Morgan Stanley reduced its target to $50 (reported via American Banking News) but retained a view that implies meaningful upside versus the current price. Morgan Stanley lowers PT
• Positive Sentiment: Wells Fargo cut its PT to $42 but stayed “overweight,” signaling that analysts still see outperformance potential despite the downward revision. Wells Fargo lowers PT TickerReport
• Positive Sentiment: Barclays trimmed its target to $41 but kept an “overweight” stance, leaving modest upside that supports the stock relative to peers. Barclays lowers PT
• Neutral Sentiment: Cantor Fitzgerald lowered its target to $40 and moved to a “neutral” rating, reflecting a more cautious stance that is unlikely to drive strong buying or selling by itself. Cantor Fitzgerald note
• Neutral Sentiment: Keefe, Bruyette & Woods reduced its price target (reported to $49) — another downward revision that adds to the consensus reset but did not alone change the narrative. Keefe Bruyette lowers PT
• Neutral Sentiment: Coverage roundup/analyst commentary pieces (e.g., Globe and Mail summary) circulated, consolidating the mixed analyst views without introducing new catalyst. Globe and Mail roundup
• Negative Sentiment: JPMorgan cut its target to $43 and moved to “underweight,” representing a clear negative signal from a major house and contributing to downside pressure on the shares. JPMorgan lowers PT

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.